Apr 18, 2008
Fifth DSMB Meeting Supports Neurobiological Technologies' Continuation Of Phase 3 Stroke Trials With Viprinex
Main Category: Stroke / Neuroprotection Also Included In: Pharma Industry / Biotech Industry Clinical Trials / Drug Trials Neurobiological Technologies, Inc. via MediLexicon
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Buck Institute, partner target Alzheimer's (from Mar '08) | Mar '08 | dan | 1 |
